174 related articles for article (PubMed ID: 6208014)
1. Differential effects of two phosphodiesterase inhibitors on fat cell metabolism.
Shechter Y
Endocrinology; 1984 Nov; 115(5):1787-91. PubMed ID: 6208014
[TBL] [Abstract][Full Text] [Related]
2. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
Elks ML; Manganiello VC
Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
[TBL] [Abstract][Full Text] [Related]
3. Effects of different phosphodiesterase inhibitors on the antilipolytic action of insulin in human adipocytes.
Kather H; Scheurer A
Horm Metab Res; 1987 Aug; 19(8):379-81. PubMed ID: 2822563
[TBL] [Abstract][Full Text] [Related]
4. The role of insulin-sensitive phosphodiesterase in insulin action.
Makino H; Suzuki T; Kajinuma H; Yamazaki M; Ito H; Yoshida S
Adv Second Messenger Phosphoprotein Res; 1992; 25():185-99. PubMed ID: 1372810
[TBL] [Abstract][Full Text] [Related]
5. Effects of inhibitors of cyclic nucleotide phosphodiesterase on actions of cholecystokinin, bombesin, and carbachol on pancreatic acini.
Gardner JD; Sutliff VE; Walker MD; Jensen RT
Am J Physiol; 1983 Nov; 245(5 Pt 1):G676-80. PubMed ID: 6195928
[TBL] [Abstract][Full Text] [Related]
6. The antilipolytic effect of insulin does not require adenylate cyclase or phosphodiesterase action.
Gabbay RA; Lardy HA
FEBS Lett; 1985 Jan; 179(1):7-11. PubMed ID: 2981181
[TBL] [Abstract][Full Text] [Related]
7. Effects of inhibitors of cyclic nucleotide phosphodiesterase on the actions of vasoactive intestinal peptide and secretin on pancreatic acini.
Gardner JD; Korman LY; Walker MD; Sutliff VE
Am J Physiol; 1982 Jun; 242(6):G547-51. PubMed ID: 6178297
[TBL] [Abstract][Full Text] [Related]
8. Characteristic behavioural alterations in rats induced by rolipram and other selective adenosine cyclic 3', 5'-monophosphate phosphodiesterase inhibitors.
Wachtel H
Psychopharmacology (Berl); 1982; 77(4):309-16. PubMed ID: 6182575
[TBL] [Abstract][Full Text] [Related]
9. A role for soluble cAMP phosphodiesterases in differentiation of 3T3-L1 adipocytes.
Elks ML; Manganiello VC
J Cell Physiol; 1985 Aug; 124(2):191-8. PubMed ID: 2413050
[TBL] [Abstract][Full Text] [Related]
10. Characterization of antilipolytic action of polyamines in isolated rat adipocytes.
Richelsen B; Pedersen SB; Hougaard DM
Biochem J; 1989 Jul; 261(2):661-5. PubMed ID: 2476118
[TBL] [Abstract][Full Text] [Related]
11. Methylxanthine and non-xanthine phosphodiesterase inhibitors. Their effects on adenosine uptake and the low Km cyclic AMP phosphodiesterase in intact rat adipocyte.
Wong EH; Ooi SO
Biochem Pharmacol; 1985 Aug; 34(16):2891-6. PubMed ID: 2411270
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of Ro 20-1724 and isobutylmethylxanthine on the basal force of contraction and beta-adrenoceptor-mediated response in the rat ventricular myocardium.
Katano Y; Endoh M
Biochem Biophys Res Commun; 1990 Feb; 167(1):123-9. PubMed ID: 1689999
[TBL] [Abstract][Full Text] [Related]
13. Resensitization of hepatocyte glucagon-stimulated adenylate cyclase can be inhibited when cyclic AMP phosphodiesterase inhibitors are used to elevate intracellular cyclic AMP concentrations to supraphysiological values.
Murphy GJ; Houslay MD
Biochem J; 1988 Jan; 249(2):543-7. PubMed ID: 2449179
[TBL] [Abstract][Full Text] [Related]
14. Antilipolytic action of insulin: role of cAMP phosphodiesterase activation.
Elks ML; Manganiello VC
Endocrinology; 1985 May; 116(5):2119-21. PubMed ID: 2985373
[TBL] [Abstract][Full Text] [Related]
15. Chronic exposure of rat fat cells to insulin enhances lipolysis and activation of partially purified hormone-sensitive lipase.
Kang ES; Betts D; Fain JN; Bahouth SW; Myers LK
Diabetes; 1993 Oct; 42(10):1415-24. PubMed ID: 8397127
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibitors of specific phosphodiesterases in intact adipocytes.
Manganiello V; Degerman E; Elks M
Methods Enzymol; 1988; 159():504-20. PubMed ID: 2457789
[No Abstract] [Full Text] [Related]
17. Role of adenosine 3',5'-monophosphate and the Ri-receptor Gi-coupled adenylate cyclase inhibitory pathway in the mechanism whereby adrenalectomy increases the adenosine antilipolytic effect in rat fat cells.
de Mazancourt P; Lacasa D; Giot J; Giudicelli Y
Endocrinology; 1989 Mar; 124(3):1131-9. PubMed ID: 2465135
[TBL] [Abstract][Full Text] [Related]
18. Methylisobutylxanthine blocks insulin antagonism of cAMP-stimulated glycogenolysis at a site distinct from phosphodiesterase. Evidence favoring an insulin-insensitive calcium release mechanism.
Gabbay RA; Lardy HA
J Biol Chem; 1986 Mar; 261(9):4002-7. PubMed ID: 2419337
[TBL] [Abstract][Full Text] [Related]
19. Papaverine and Ro 20-1724 inhibit cyclic nucleotide phosphodiesterase activity and increase cyclic AMP levels in psoriatic epidermis in vitro.
Rusin LJ; Duell EA; Voorhees JJ
J Invest Dermatol; 1978 Aug; 71(2):154-6. PubMed ID: 210235
[TBL] [Abstract][Full Text] [Related]
20. The antilipolytic effect of insulin in human adipocytes requires activation of the phosphodiesterase.
Lönnroth P; Smith U
Biochem Biophys Res Commun; 1986 Dec; 141(3):1157-61. PubMed ID: 2434081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
